What HCA Healthcare, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 13 |
| Total trades | 1 | 70 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 314,994 |
| Disposed | 7,769 | 236,708 |
| Net activity | −7,769 | +78,286 |
Common stock only — 13 reported trades in the last 12 months are in a security these totals do not cover.
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| McAlevey Michael R | EVP & Chief Legal & Admin Off. | Aug 26 | Other Transaction · J | −7,769 | $429.00 | −$3.33M | 0 |
| Marks Mike A | EVP and CFO | May 07 | Gift · G | +3,336 | — | — | 46,576 |
| Marks Mike A | EVP and CFO | May 07 | Gift · G | −3,336 | — | — | 0 |
| Frist Thomas F Iii | Director | Apr 28 | Grant / award · A | +1,041 | — | — | 15,858 |
| Frist William R | Director | Apr 28 | Grant / award · A | +809 | — | — | 13,740 |
| Michelson Michael W | Director | Apr 28 | Grant / award · A | +925 | — | — | 12,576 |
| Deparle Nancy Ann | Director | Apr 28 | Grant / award · A | +509 | — | — | 21,910 |
| Johnston Hugh F | Director | Apr 28 | Grant / award · A | +809 | — | — | 4,475 |
| Chidsey John | Director | Apr 28 | Grant / award · A | +809 | — | — | 1,305 |
| Smith Andrea B | Director | Apr 28 | Grant / award · A | +509 | — | — | 4,666 |
| Riley Wayne Joseph | Director | Apr 28 | Grant / award · A | +509 | — | — | 15,029 |
| McAlevey Michael R | EVP & Chief Legal & Admin Off. | Feb 18 | Open-market sale · S | −1,694 | $533.37 | −$904K | 8,853 |
| McAlevey Michael R | EVP & Chief Legal & Admin Off. | Feb 13 | Withheld — tax / exercise cost · F | −3,306 | $540.29 | −$1.79M | 10,547 |
| McAlevey Michael R | EVP & Chief Legal & Admin Off. | Feb 13 | Exercise / conversion · M | +5,000 | $236.61 | +$1.18M | 13,853 |
| Berres Jennifer | SVP & Chief Human Res. Officer | Feb 11 | Open-market sale · S | −4,010 | $526.16 | −$2.11M | 11,993 |
| Berres Jennifer | SVP & Chief Human Res. Officer | Feb 11 | Open-market sale · S | −4,010 | $503.00 | −$2.02M | 16,003 |
| Wyatt Christopher F. | SVP & Controller | Feb 11 | Open-market sale · S | −4,000 | $505.00 | −$2.02M | 44,379 |
| Cuffe Michael S. | EVP and Chief Clinical Officer | Feb 10 | Withheld — tax / exercise cost · F | −3,501 | $502.05 | −$1.76M | 32,080 |
| Cuffe Michael S. | EVP and Chief Clinical Officer | Feb 10 | Grant / award · A | +9,628 | — | — | 35,581 |
| Berres Jennifer | SVP & Chief Human Res. Officer | Feb 10 | Withheld — tax / exercise cost · F | −2,515 | $502.05 | −$1.26M | 20,013 |
Loading...
